Lonidamine cytotoxicity: involvement of the lysosomal compartment
Related Experiment Video
Updated: Oct 9, 2026

Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay
Published on: September 10, 2018
P Dell'Antone1, M Bragadin, L Piergallini
1Department of Experimental and Biomedical Sciences, University of Padova, Italy.
Abstract:
Lonidamine (LND) was found to decrease significantly the pH gradient across intracellular compartments in Ehrlich ascites tumour cells. The effect was maximal in the range 0.2 - 0.3 mM LND, and was observed both in the presence of glucose - i.e. conditions in which a high bioenergetic status of the cells was maintained by glycolysis (due to a strong Crabtree effect in these cells) - and in the absence of glucose. Moreover the LND effect was also observed in the presence of bafilomycin, a specific inhibitor of the H+ -vacuolar ATP-ase. Based on these findings, we suggest that the LND effect on the proton gradient reflects an LND-induced increase in membrane proton conductance. The consequent impairment of intracellular proton gradients might be involved in the mechanism of action of LND, allowing drugs that are weak bases to accumulate preferentially in the cytoplasm and nucleus.
Related Concept Videos
Lysosomal Hydrolases
Drugs Affecting Neurotransmitter Release or Uptake
Drug Toxicity: Dose-Dependent Reactions
